IRCAD France welcomes EndoQuest’s groundbreaking robotic system

A groundbreaking development has taken place at IRCAD in France, as EndoQuest, the leading flexible robotic endoscopy company, has successfully installed its state-of-the-art robot. This advanced technology will be instrumental in fostering research programs focused on endoluminal and percutaneous surgery.

IRCAD, in conjunction with Harvard, stands as the sole research center worldwide to possess this remarkable robotic system.

Recently, IRCAD hosted an international scientific advisory board meeting, graced by esteemed individuals including Mr. Hamid JAFAR, the principal investor, Mr. Kurt AZARBARZIN, the CEO, and Dr. Todd WILSON, the CMO, all representing EndoQuest. In addition, numerous globally recognized key opinion leaders in the field of robotics were also in attendance.

Many thanks to:

– Mr. Neeraj AGRAWAL Board of Directors of Endoquest and member of Crescent group
– Mr. Nicholas DRYSDALE Member of Crescent group
– Mr. Eduardo FONSECA Board of Directors of Endoquest and member of Crescent group
– Dr. Fred MOLL International Advisory Board member of EndoQuest
– Dr. Santiago HORGAN International Advisory Board member of EndoQuest
– Prof. Ricardo ESTAPE Clinical Advisory Board Member of EndoQuest
– Prof. Vipul PATEL Board of Directors of Endoquest and International Advisory Board member of Endoquest
– Dr. Chris THOMPSON International Advisory Board member of EndoQuest
– Dr. Jad KAOUK Clinical Advisory Board Member of EndoQuest
– Mr. Chris KLECHER Senior VP of Sales
– Mr. John MAGNASCO VP of Quality and Regulatory
– Mr. Perry GENOVA Senior VP of R&D

IRCAD Contact form

COVID19: IRCAD sanitary measures & health pass

Please note that the IRCAD administrative board and staff are closely monitoring the evolving COVID-19 situation, in full compliance with all applicable laws and regulations in France. The health, safety, and well-being of our participants, experts and staff are our top priority!
Despite the current context, the IRCAD stands firmly by your side to help you acquire knowledge and skills. Come and join us !

We would like to draw your attention that the « Vaccine Pass » is now mandatory in France since end of January 2022 and replaces the former « Health Pass » to access places that are open to the public, such as cinemas, museums, cafés and restaurants, hotels as well as the IRCAD Institute which welcomes participants in the framework of its courses and seminars. Thus, a PCR test without vaccination is no longer sufficient to take part in our courses.

The vaccine pass includes a proof of the following (one of the 3 items is sufficient):

  • The vaccination certificate, proving that persons have a complete vaccination (as of January 15, 2022, all persons aged 18 and over must receive a booster dose no more than 7 months after their last injection or Covid infection to receive a valid vaccination pass. As of February 15, 2022, the time limits for keeping the pass will be reduced, you will have to do your booster dose 4 months and no longer 7 months after your 2nd dose to have a complete vaccine schedule and maintain a valid vaccine pass)
  • The result of a positive RT-PCR or antigenic test attesting to the recovery of Covid, more than 11 days and less than 4 months
  • The certificate of contraindication to vaccination

Further information about the new vaccine pass can be found at :

We very much hope to be able to count on your kind understanding of those rules which have been set by the French Government and which our Institute is required to apply